Cyp26a1 - cytochrome P450, family 26, subfamily a, polypeptide 1 Gene

Also Known as Cyp26

Species: Rattus norvegicus

Gene Type: protein coding
Gene ID: 154985

Summary

Predicted to enable monooxygenase activity and retinoic acid binding activity. Involved in kidney development; response to retinoic acid; and response to vitamin A. Orthologous to human CYP26A1 (Cytochrome P450 family 26 subfamily A member 1). [provided by Alliance of Genome Resources, Apr 2022]

Cyp26a1 Products (1)

mRNA Protein Name
NM_130408.2 NP_569092.2 cytochrome P450, family 26, subfamily a, polypeptide 1

Gene Ontology

  • Biological Process
Biological Process GO Annotation Evidence References Source
involved in kidney development IEP
IEP: Inferred from expression pattern
15567713 RGD
involved in response to retinoic acid IEP
IEP: Inferred from expression pattern
19700416 RGD
involved in response to vitamin A IEP
IEP: Inferred from expression pattern
19700416 RGD
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

cytochrome P450, family 26, subfamily a, polypeptide 1

  • cytochrome P450, 26, retinoic acid

  • retinoic acid hydrolase

  • retinoic acid hydroxylase

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-14531 Talarozole Inhibitor 99.75% Phase 2

Pre-clinical Phase

Bioactive Molecules (5)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-169863 DC360 Agonist / Unkown
HY-182728 CD564 Inhibitor / Unkown
HY-RS03447 CYP26A1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS03448 CYP26B1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS03449 CYP26C1 Human Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Cyp26a1 NCBI NCBI:1592